T. Rowe Price Associates’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-128,452
Closed -$60K 3087
2022
Q2
$60K Sell
128,452
-425
-0.3% -$540 ﹤0.01% 2839
2022
Q1
$298K Buy
128,877
+5,121
+4% +$15K ﹤0.01% 2554
2021
Q4
$465K Sell
123,756
-86,675
-41% -$420K ﹤0.01% 2419
2021
Q3
$682K Buy
210,431
+51,800
+33% +$183K ﹤0.01% 2230
2021
Q2
$742K Sell
158,631
-6,690
-4% -$38.4K ﹤0.01% 2199
2021
Q1
$1.23M Sell
165,321
-66,588
-29% -$540K ﹤0.01% 1960
2020
Q4
$1.67M Buy
231,909
+30,307
+15% +$158K ﹤0.01% 1705
2020
Q3
$665K Buy
201,602
+61,343
+44% +$197K ﹤0.01% 1977
2020
Q2
$481K Buy
140,259
+18,335
+15% +$70.2K ﹤0.01% 2063
2020
Q1
$451K Sell
121,924
-62,493
-34% -$317K ﹤0.01% 2034
2019
Q4
$865K Buy
184,417
+11,795
+7% +$52.6K ﹤0.01% 1951
2019
Q3
$554K Buy
172,622
+1,400
+0.8% +$4.51K ﹤0.01% 2055
2019
Q2
$705K Buy
171,222
+497
+0.3% +$3.14K ﹤0.01% 1984
2019
Q1
$1.37M Buy
170,725
+19,671
+13% +$185K ﹤0.01% 1720
2018
Q4
$1.1M Buy
151,054
+67,832
+82% +$931K ﹤0.01% 1762
2018
Q3
$1.4M Buy
83,222
+717
+0.9% +$10.2K ﹤0.01% 1727
2018
Q2
$778K Buy
82,505
+393
+0.5% +$2.64K ﹤0.01% 1951
2018
Q1
$488K Buy
82,112
+19,592
+31% +$137K ﹤0.01% 2100
2017
Q4
$485K Sell
62,520
-19,630
-24% -$147K ﹤0.01% 2103
2017
Q3
$704K Buy
82,150
+40
+0% +$385 ﹤0.01% 1944
2017
Q2
$917K Sell
82,110
-612,195
-88% -$7.19M ﹤0.01% 1818
2017
Q1
$7.75M Sell
694,305
-383,262
-36% -$4.76M ﹤0.01% 1376
2016
Q4
$17.7M Sell
1,077,567
-360,298
-25% -$6.34M ﹤0.01% 1177
2016
Q3
$29M Buy
1,437,865
+57,620
+4% +$1.15M 0.01% 999
2016
Q2
$21.5M Sell
1,380,245
-1,470,548
-52% -$30.5M ﹤0.01% 1077
2016
Q1
$80.3M Buy
2,850,793
+1,446,976
+103% +$68.3M 0.02% 612
2015
Q4
$85.9M Sell
1,403,817
-27,200
-2% -$1.65M 0.02% 596
2015
Q3
$99.1M Buy
1,431,017
+108,195
+8% +$8.66M 0.02% 576
2015
Q2
$105M Buy
1,322,822
+194,200
+17% +$16.8M 0.02% 587
2015
Q1
$101M Buy
1,128,622
+914,907
+428% +$76.5M 0.02% 606
2014
Q4
$15.4M Buy
213,715
+9,104
+4% +$624K ﹤0.01% 1199
2014
Q3
$14M Buy
204,611
+62,713
+44% +$4.13M ﹤0.01% 1217
2014
Q2
$9.94M Buy
141,898
+97,906
+223% +$6.55M ﹤0.01% 1319
2014
Q1
$3.02M Buy
43,992
+2,773
+7% +$197K ﹤0.01% 1499
2013
Q4
$2.78M Sell
41,219
-5,200
-11% -$297K ﹤0.01% 1491
2013
Q3
$2.11M Sell
46,419
-557,400
-92% -$22.4M ﹤0.01% 1541
2013
Q2
$22.2M Buy
+603,819
New +$21.7M 0.01% 1040

Other funds holding ENDP

T. Rowe Price Associates's ENDP Position: Q3 2022 in Review

T. Rowe Price Associates sold out of Endo International plc (ENDP) in Q3 2022, closing a stake of 128,452 shares — an estimated $60K sold.

T. Rowe Price Associates first reported a position in ENDP in Q2 2013 and held it in 37 quarters. The position peaked at $105M in Q2 2015. 12 funds tracked by Wall St. Rank hold ENDP as of Q3 2022.

  • T. Rowe Price Associates reported no remaining Endo International plc position as of Q3 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 128,452 Endo International plc shares in Q3 2022, an estimated $60K.
  • T. Rowe Price Associates first reported a position in Endo International plc in Q2 2013 and held it in 37 quarters.
  • T. Rowe Price Associates's Endo International plc position peaked at $105M in Q2 2015.
  • 12 funds tracked by Wall St. Rank held Endo International plc as of Q3 2022.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.